Int J Pharm. 2013 Dec 31;458(2):305-14.
N-trimethyl chitosan (TMC) with different degree of quaternization (DQ) as the coating materials, vitamin A palmitate (VAP)-loaded cationic liposomes dispersed in thermo-sensitive in situ gels (ISG) with poloxamer 407 (P407) as the base were prepared in this study. VAP-loaded liposomes (VAPL) were prepared using a film dispersion method followed by TMC-coating with DQ of 20%, 40% and 60% (TMC20, TMC40 and TMC60), respectively, then dispersed in P407 solution to obtain TMC-coated VAPL ISG. The in vitro properties of the system including morphology, size, zeta potential, entrapment efficiency, drug release and ocular retention were investigated. The ocular retention in vivo, eye irritation and pharmacokinetics in aqueous humor of the system were also studied in rabbits. VAPL revealed a spherical surface with mean size below 100 nm and negative zeta potential. After TMC-coating, the morphology and entrapment efficiency showed no significant changes, while the mean size was increased, zeta potential was changed into positive, and drug release was further sustained, and above all was influenced by DQ of TMC. TMC-coated VAPL exhibited little effect on the gelation temperature of P407 solution, and at the P407 concentration of 25% (w/v), TMC-coated VAPL ISG had the gelation temperature closest to the eye surface (34 °C) after diluted by the artificial tears. Compared with uncoated VAPL ISG and the marketed Oculotect gels, TMC-coated VAPL ISG displayed more retarded drug release and gel corrosion with a good linear relationship between them, and the higher DQ was, the slower drug release and gel corrosion. The ocular retention time in vitro and in vivo of TMC-coated VAPL ISG were both notable prolonged with a positive correlation with DQ of TMC. Compared with the marketed gels, TMC60-coated VAPL ISG showed delayed Tmax, improved Cmax and AUC(0–24) in rabbit aqueous humor, suggesting the sustained drug release and better corneal penetration and absorption. The local irritation of TMC-coated VAPL ISG was proved to be negligible. TMC-coated VAPL ISG with the properties of sustained drug release, prolonged ocular retention, improved corneal penetration and promising bio-safety is valuable to be studied further.
N-三甲基壳聚糖(TMC)具有不同程度的季铵化(DQ)作为涂层材料,维生素 A 棕榈酸酯(VAP)负载的阳离子脂质体分散在泊洛沙姆 407(P407)作为基质的温敏原位凝胶(ISG)中。VAP 负载的脂质体(VAPL)采用薄膜分散法制备,然后分别用 DQ 为 20%、40%和 60%的 TMC 进行涂层(TMC20、TMC40 和 TMC60),然后分散在 P407 溶液中得到 TMC 涂层的 VAPL ISG。对系统的体外性质,包括形态、大小、Zeta 电位、包封效率、药物释放和眼内保留进行了研究。还在兔体内研究了系统的体内眼保留、眼刺激性和房水药代动力学。VAPL 呈现出表面呈球形,平均粒径小于 100nm,Zeta 电位为负。TMC 涂层后,形态和包封效率没有明显变化,而平均粒径增加,Zeta 电位变为正,药物释放进一步得到持续,并且所有这些都受 TMC 的 DQ 影响。TMC 涂层的 VAPL 对 P407 溶液的凝胶化温度影响不大,在 P407 浓度为 25%(w/v)时,经人工泪液稀释后,TMC 涂层的 VAPL ISG 的凝胶化温度最接近眼表面(34°C)。与未涂层的 VAPL ISG 和市售的 Oculotect 凝胶相比,TMC 涂层的 VAPL ISG 显示出更缓慢的药物释放和凝胶腐蚀,并且与它们之间存在良好的线性关系,DQ 越高,药物释放和凝胶腐蚀越慢。TMC 涂层的 VAPL ISG 的体外和体内眼保留时间均显著延长,与 TMC 的 DQ 呈正相关。与市售凝胶相比,TMC60 涂层的 VAPL ISG 显示出延迟的 Tmax,提高的 Cmax 和 AUC(0-24)在兔眼房水中,表明药物释放持续时间更长,角膜穿透和吸收更好。TMC 涂层的 VAPL ISG 的局部刺激性被证明可以忽略不计。具有持续药物释放、延长眼保留、改善角膜穿透和有前途的生物安全性的 TMC 涂层的 VAPL ISG 具有进一步研究的价值。